|Articles|June 16, 2021
Roche Pharma’s new approach to Upstream Process Development
Author(s)Roche
Roche Pharma Research and Early Development lab automation specialist, Pawel Linke, discusses their approach to doubling the number of projects in process development without significantly increasing headcount.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
New Draft Guidance Highlights FDA Push Toward Human-Relevant Safety Models
2
Regulatory Uncertainty Surfaces as FDA Blames COVID Vaccines for 10 Child Deaths
3
Rentschler–Coriolis Partnership Reflects Demand for Connected Biopharma Workflows
4
Implementing Automation and Flexible Design for Allogeneic Manufacturing
5
